MiR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway

American Journal of Pathology

Volumn 184, Issue 8, 2014, Pages 2355-2364

  Qadir, Ximena V ^a   Han, Chang ^a   Lu, Dongdong ^a   Zhang, Jinqiang ^a   Wu, Tong ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; MICRORNA; MICRORNA 185; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; MIRN185 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DNA METHYLATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; TUMOR INVASION; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MICE; MICE, SCID; MICRORNAS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84904618392     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.05.004     Document Type: Article

References (38)

1. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674 687
2. L.B. Seeff, and J.H. Hoofnagle Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity Oncogene 25 2006 3771 3777
3. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
4. J.M. Llovet, and J. Bruix Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 2008 1312 1327
5. S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
6. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
7. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: a global view Nat Rev Gastroenterol Hepatol 7 2010 448 458
8. A. Villanueva, and J.M. Llovet Targeted therapies for hepatocellular carcinoma Gastroenterology 140 2011 1410 1426
9. M.A. Valencia-Sanchez, J. Liu, G.J. Hannon, and R. Parker Control of translation and mRNA degradation by miRNAs and siRNAs Genes Dev 20 2006 515 524
10. S.S. Thorgeirsson, J.S. Lee, and J.W. Grisham Functional genomics of hepatocellular carcinoma Hepatology 43 2006 S145 S150
11. R.N. Aravalli, C.J. Steer, and E.N. Cressman Molecular mechanisms of hepatocellular carcinoma Hepatology 48 2008 2047 2063
12. S. Giordano, and A. Columbano MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57 2013 840 847
13. F. Borel, P. Konstantinova, and P.L. Jansen Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma J Hepatol 56 2012 1371 1383
14. T. Kogure, W.L. Lin, I.K. Yan, C. Braconi, and T. Patel Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth Hepatology 54 2011 1237 1248
15. G. Szabo, and S. Bala MicroRNAs in liver disease Nat Rev Gastroenterol Hepatol 10 2013 542 552
16. G. Szabo, P. Sarnow, and S. Bala MicroRNA silencing and the development of novel therapies for liver disease J Hepatol 57 2012 462 466
17. A. Budhu, H.L. Jia, M. Forgues, C.G. Liu, D. Goldstein, A. Lam, K.A. Zanetti, Q.H. Ye, L.X. Qin, C.M. Croce, Z.Y. Tang, and X.W. Wang Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907
18. Q. Zhi, J. Zhu, X. Guo, S. He, X. Xue, J. Zhou, B. Hu, H. Li, S. Chen, H. Zhao, and Y. Kuang Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage Biomed Pharmacother 67 2013 393 398
19. L. Yin, W.J. Cai, C.X. Liu, Y.Z. Chen, J.M. Hu, J.F. Jiang, H.A. Li, X.B. Cui, X.Y. Chang, W.J. Zhang, K. Sun, and F. Li Analysis of PTEN methylation patterns in soft tissue sarcomas by MassARRAY spectrometry PLoS One 8 2013 e62971
20. T. Chen, S. Hevi, F. Gay, N. Tsujimoto, T. He, B. Zhang, Y. Ueda, and E. Li Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells Nat Genet 39 2007 391 396
21. I.Y. Park, B.H. Sohn, E. Yu, D.J. Suh, Y.H. Chung, J.H. Lee, S.J. Surzycki, and Y.I. Lee Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein Gastroenterology 132 2007 1476 1494
22. H. You, W. Ding, and C.B. Rountree Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta Hepatology 51 2010 1635 1644
23. R. Hino, H. Uozaki, N. Murakami, T. Ushiku, A. Shinozaki, S. Ishikawa, T. Morikawa, T. Nakaya, T. Sakatani, K. Takada, and M. Fukayama Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma Cancer Res 69 2009 2766 2774
24. N.T. Phuong, S.K. Kim, S.C. Lim, H.S. Kim, T.H. Kim, K.Y. Lee, S.G. Ahn, J.H. Yoon, and K.W. Kang Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells Breast Cancer Res Treat 130 2011 73 83
25. M. Peyrou, L. Bourgoin, and M. Foti PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer Dig Dis 28 2010 236 246
26. K.M. Sze, K.L. Wong, G.K. Chu, J.M. Lee, T.O. Yau, and I.O. Ng Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance Hepatology 53 2011 1558 1569
27. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
28. T. Tian, K.J. Nan, H. Guo, W.J. Wang, Z.P. Ruan, S.H. Wang, X. Liang, and C.X. Lu PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway Oncol Rep 23 2010 1593 1600
29. J.S. Chen, Q. Wang, X.H. Fu, X.H. Huang, X.L. Chen, L.Q. Cao, L.Z. Chen, H.X. Tan, W. Li, J. Bi, and L.J. Zhang Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9 Hepatol Res 39 2009 177 186
30. N.I. Herath, B.A. Leggett, and G.A. MacDonald Review of genetic and epigenetic alterations in hepatocarcinogenesis J Gastroenterol Hepatol 21 2006 15 21
31. G.L. Gravina, C. Festuccia, F. Marampon, V.M. Popov, R.G. Pestell, B.M. Zani, and V. Tombolini Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation Mol Cancer 9 2010 305
32. X. Yang, F. Lay, H. Han, and P.A. Jones Targeting DNA methylation for epigenetic therapy Trends Pharmacol Sci 31 2010 536 546
33. Y. Kanai, and S. Hirohashi Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state Carcinogenesis 28 2007 2434 2442
34. A.M. Deaton, and A. Bird CpG islands and the regulation of transcription Genes Dev 25 2011 1010 1022
35. U. Schagdarsurengin, L. Wilkens, D. Steinemann, P. Flemming, H.H. Kreipe, G.P. Pfeifer, B. Schlegelberger, and R. Dammann Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma Oncogene 22 2003 1866 1871
36. J. Yu, M. Ni, J. Xu, H. Zhang, B. Gao, J. Gu, J. Chen, L. Zhang, M. Wu, S. Zhen, and J. Zhu Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis BMC Cancer 2 2002 29
37. M. Berdasco, and M. Esteller Aberrant epigenetic landscape in cancer: how cellular identity goes awry Dev Cell 19 2010 698 711
38. M. Fabbri, and G.A. Calin Epigenetics and miRNAs in human cancer Adv Genet 70 2010 87 99